ホーム > 田尻 和子/ Tajiri, Kazuko

田尻 和子

ALUMNI 2026年6月現在、筑波大学が主たる所属機関ではありません

Tajiri, Kazuko

国立研究開発法人国立がん研究センター東病院 , 循環器科 , 科長
National Cancer Center Hospital East , Department of Cardiology, , Chief

http://www.md.tsukuba.ac.jp/clinical-med/cardiology/

関連記事はまだありません。

  1. 1. Clinical Characteristics and Outcomes of Heart Failure with Preserved Ejection Fraction Versus Reduced Ejection Fraction in Patients Receiving Anticancer Drugs. Yuma Shibutani; Fuka Aoki; Takuro Imaoka; Atsuko SuzukiKazuko Tajiri
      Cardiovascular toxicology 26: (2026)
  2. 2. Toward Better Cardiovascular Risk Prediction in Cancer Survivors. Kazuko Tajiri
      The Canadian journal of cardiology (2026) Semantic Scholar
  3. 3. Myocardial Expression of PD-L1 as a Marker of Poor Prognosis in Immune Checkpoint Inhibitor-Associated Myocarditis. Takuro Imaoka; Shingo Sakashita; Satoshi Matsuoka; Kimi Sato (+8 著者) Kazuko Tajiri
      JACC. CardioOncology 8: 168 (2026) Semantic Scholar
  4. 4. Feasibility study protocol for the evaluation of home blood pressure in patients receiving angiogenesis inhibitor therapy: a multicenter observational study. Kaori Kitaoka; Satoshi Morimoto; Shintaro Minegishi; Hiroshi Kato (+10 著者) Akira Nishiyama
      Hypertension research : official journal of the Japanese Society of Hypertension 49: 1441 (2026) Semantic Scholar
  5. 5. BET Inhibitor JQ1 Attenuates Atrial Fibrillation Through Modulation of Fibrosis, Calcium Homeostasis, and Mitochondrial Function in a Murine Model. Zonghu Song; Nobuyuki Murakoshi; Dongzhu Xu; Binyang Xi (+3 著者) Tomoko Ishizu
      International journal of molecular sciences 26: (2025) Semantic Scholar
  6. 6. Cytokine profiling of patients with immune checkpoint inhibitor-associated myocarditis: a pilot study. Siqi Li; Kazuko Tajiri; Yuki Ishizuka; Yoshiko Murakata (+3 著者) Tomoko Ishizu
      Molecular biology reports 52: 983 (2025) Semantic Scholar
  7. 7. CD300a immunoreceptor regulates ischemic tissue damage and adverse remodeling in the mouse heart and kidney. Nanako Nishiyama; Hitoshi Koizumi; Chigusa Nakahashi-Oda; Satoshi Fujiyama (+11 著者) Akira Shibuya
      The Journal of clinical investigation 135: (2025) Semantic Scholar
  8. 8. Incidence and Risk of Hypertension and Proteinuria in Cancer Patients Treated with Lenvatinib: A Systematic Review and Meta-analysis. Yuma Shibutani; Atsuko Suzuki; Takuro Imaoka; Kazuko Tajiri
      The oncologist 30: (2025) Semantic Scholar
  9. 9. Multi-scale Feature Learning with CNN-RNN-Attention Framework for ECG-based Cancer Therapy-Related Cardiac Dysfunction Detection Natsu Suyama; Akira Furui; Takio Kurita; Kazuko Tajiri
      Proceedings of the 47th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC2025) 2025: 1 (2025)
  10. 10. Effects of Immune Checkpoint Inhibitor-induced Thyroid Dysfunction on Cardiac Troponin Levels. Yuma Shibutani; Atsushi Kawanobe; Shinya Suzuki; Takuro ImaokaKazuko Tajiri
      Journal of immunotherapy (Hagerstown, Md. : 1997) 48: 183 (2025) Semantic Scholar
  11. 11. A Fatal Case of Immune Checkpoint Inhibitor-Associated Myocarditis with Severe Right Ventricular Failure. Takuro Imaoka; Kimi Sato; Shingo Sakashita; Yuma Shibutani (+3 著者) Kazuko Tajiri
      International heart journal 66: 511 (2025) Semantic Scholar
  12. 12. Effects of Immune Checkpoint Inhibitor-induced Thyroid Dysfunction on Cardiac Troponin Levels. Yuma Shibutani; Atsushi Kawanobe; Shinya Suzuki; Takuro ImaokaKazuko Tajiri
      Journal of immunotherapy (Hagerstown, Md. : 1997) (2025) Semantic Scholar
  13. 13. Withdrawal of Cardioprotective Therapy in Patients With Recovered Cancer Therapy-Related Cardiac Dysfunction. Yuma Shibutani; Takuro Imaoka; Atsuko Suzuki; Kazuko Tajiri
      JACC. CardioOncology 7: 189 (2025) Semantic Scholar
  14. 14. Risk of recurrence and bleeding in patients with cancer-associated venous thromboembolism in the direct oral anticoagulants era: Findings from the TULIPE registry. Yuki Ishizuka; Kazuko Tajiri; Hiroyuki Naito; Momoko Murata (+2 著者) Tomoko Ishizu
      PloS one 20: e0329025 (2025) Semantic Scholar
  15. 15. Asymptomatic Troponin Elevation and Early Mortality Following Immune Checkpoint Inhibitor Therapy in Patients Without Cardiac Adverse Events. Yuma Shibutani; Takuro Imaoka; Atsuko Suzuki; Kazuko Tajiri
      Cancer diagnosis & prognosis 5: 634 (2025) Semantic Scholar
  16. 16. 4E-BP3 deficiency impairs dendritic cell activation and CD4+ T cell differentiation and attenuates α-myosin-specific T cell-mediated myocarditis in mice. Siqi Li; Kazuko Tajiri; Zixun Yuan; Yoshiko Murakata (+3 著者) Nobuyuki Murakoshi
      Basic research in cardiology 120: 225 (2024) Semantic Scholar
  17. 17. Addressing Cardiotoxicity Risks in Long-term Use of Human Epidermal Growth Factor Receptor 2 Inhibitors. Kazuko Tajiri
      Internal medicine (Tokyo, Japan) 64: 1784 (2024) Semantic Scholar
  18. 18. Metabolic remodeling and calcium handling abnormality in induced pluripotent stem cell-derived cardiomyocytes in dilated phase of hypertrophic cardiomyopathy with MYBPC3 frameshift mutation. Haruka Mori; Dongzhu Xu; Yuzuno Shimoda; Zixun Yuan (+7 著者) Nobuyuki Murakoshi
      Scientific reports 14: 15422 (2024) Semantic Scholar
  19. 19. Impact of cancer in patients with aortic stenosis undergoing transcatheter aortic valve replacement: A systematic review and meta-analysis. Takumi Osawa; Kazuko Tajiri; Tomoya Hoshi; Masaki IedaTomoko Ishizu
      International journal of cardiology. Heart & vasculature 52: 101410 (2024) Semantic Scholar
  20. 20. Immune Checkpoint Inhibitor Myotoxicities: An Autoimmune Perspective. Kazuko Tajiri
      Internal medicine (Tokyo, Japan) 63: 3129 (2024) Semantic Scholar
1 2 3 … 8
  1. 1. 薬剤師と腫瘍専門医のためのがん薬物療法に役立つ腫瘍循環器診療ポケットブック 岡, 亨; 高木, 麻里; 小室, 一成 (担当:分担執筆, 範囲:心筋炎)
    金芳堂 2026年3月 (ISBN: 9784765320887)
  2. 2. 今日の治療指針 福井, 次矢; 高木, 誠; 小室, 一成; 阿部, 理一郎 (担当:分担執筆, 範囲:心臓腫瘍)
    医学書院 2026年1月 (ISBN: 9784260062480)
  3. 3. 腫瘍循環器診療ハンドブック 日本腫瘍循環器学会編集委員会; 南, 博信
    メジカルビュー社 2025年11月 (ISBN: 9784758324335)
  4. 4. オンコロジーエマージェンシーテキストブック 日本がんサポーティブケア学会 (担当:分担執筆, 範囲:がん治療関連心筋障害、心不全)
    金原出版 2025年10月 (ISBN: 9784307204347)
  5. 5. 最新主要文献とガイドラインでみる 循環器内科学レビュー2025-’26 (レビューシリーズ) 田尻和子 (担当:分担執筆, 範囲:(V章)心筋症・心筋炎・心膜疾患 抗がん薬による心筋症・心筋炎)
    総合医学社 2025年1月27日 (ISBN: 4883784797)
  6. 6. 今日の治療指針 2025年版[デスク判] 田尻和子 (担当:分担執筆, 範囲:心筋炎)
    医学書院 2025年1月10日 (ISBN: 4260057170)
  7. 7. 腫瘍循環器診療 実践トレーニング 田尻和子
    メジカルビュー社 2024年3月14日 (ISBN: 4758322147)
  8. 8. 今日の治療指針 : 私はこう治療している 田尻和子 (担当:分担執筆, 範囲:がんに伴う循環器疾患)
    医学書院 2024年1月 (ISBN: 9784260053426)
  9. 9. 2023年改訂版心筋炎の診断・治療に関するガイドライン 田尻和子 (担当:共著, 範囲:膠原病性心筋炎、薬剤性心筋炎、CQ1 急性心筋炎の患者に対する心筋生検の 施行は推奨されるか？)
    日本循環器学会 2023年3月
  10. 10. がん免疫療法ガイドライン 第3版 田尻和子; 他; 日本臨床腫瘍学会 (担当:共著, 範囲:心筋炎を含む心血管障害)
    金原出版 2023年3月 (ISBN: 9784307102124)
  11. 11. 腫瘍循環器診療ハンドブック 田尻和子 (担当:分担執筆, 範囲:心筋炎)
    メジカルビュー社 2020年11月 (ISBN: 9784758319669)
  12. 12. Gene delivery of Socs1 inhibits inflammatory and pathogenic responses in autoimmune myocarditis in mice 田尻, 和子
    2012年3月
  13. 13. 循環器研修ノート 下條信威; 田尻和子; 廣江道昭 (担当:分担執筆, 範囲:多臓器不全（MOF,MODS）)
    診断と治療社 2010年3月

 958 total views